Fortress Biotech Stock (NASDAQ: FBIO) stock price, news, charts, stock research, profile.
Open | $1.86 |
Close | $1.97 |
Volume / Avg. | 203.96K / 261.57K |
Day Range | $1.86 - $1.97 |
52 Wk Range | 1.24 - 6.15 |
Market Cap | $41.07M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 53 |
Short Interest | 9.54% |
Days to Cover | 9.09 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Fortress Biotech (NASDAQ:FBIO) through any online brokerage.
Other companies in Fortress Biotech’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Kezar Life Sciences (NASDAQ:KZR), Estrella Immunopharma (NASDAQ:ESLA), Gain Therapeutics (NASDAQ:GANX) and CARISMA Therapeutics (NASDAQ:CARM).
Fortress Biotech has a consensus price target of $10.14.
The stock price for Fortress Biotech (NASDAQ: FBIO) is $1.8 last updated September 12, 2024 at 5:04 PM EDT.
There are no upcoming dividends for Fortress Biotech.
Fortress Biotech’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
There is no upcoming split for Fortress Biotech.
Fortress Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.